These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27562312)

  • 41. Has equity in government subsidy on healthcare improved in China? Evidence from the China's National Health Services Survey.
    Si L; Chen M; Palmer AJ
    Int J Equity Health; 2017 Jan; 16(1):6. PubMed ID: 28069001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [What is happening within cancer drug therapy? The Danish Society of Medical Oncology].
    Dansk Selskab for Medicinsk Onkologi's bestyrelse (DMO)
    Ugeskr Laeger; 2001 Mar; 163(12):1708. PubMed ID: 11284408
    [No Abstract]   [Full Text] [Related]  

  • 43. Using Geographic Information Systems (GIS) to Examine Barriers to Healthcare Access for Hispanic and Latino Immigrants in the U.S. South.
    Edward J; Biddle DJ
    J Racial Ethn Health Disparities; 2017 Apr; 4(2):297-307. PubMed ID: 27129855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early market access of cancer drugs in the EU.
    Martinalbo J; Bowen D; Camarero J; Chapelin M; Démolis P; Foggi P; Jonsson B; Llinares J; Moreau A; O'Connor D; Oliveira J; Vamvakas S; Pignatti F
    Ann Oncol; 2016 Jan; 27(1):96-105. PubMed ID: 26487583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Access to innovation: is there a difference in the use of expensive anticancer drugs between French hospitals?
    Bonastre J; Chevalier J; Van der Laan C; Delibes M; De Pouvourville G
    Health Policy; 2014 Jun; 116(2-3):162-9. PubMed ID: 24314625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survey of the State of Implementation of the American Society of Clinical Oncology/Oncology Nursing Society Safety Standards for Chemotherapy Administration in India.
    Patil VM; Chakraborty S; Bhattacharjee A; Dessai S
    J Oncol Pract; 2015 Sep; 11(5):365-9. PubMed ID: 26265175
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Barriers to Medication Access in Pediatric Oncology in the United States.
    Kelly MJ; Sung L; Dickens DS
    J Pediatr Hematol Oncol; 2019 May; 41(4):286-288. PubMed ID: 30124549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relevance of the Spanish Society for Medical Oncology (SEOM)'s clinical oncology guidelines.
    Isla Casado D; González-Martín A; Alba Conejo E
    Clin Transl Oncol; 2010 Nov; 12(11):707-8. PubMed ID: 20974559
    [No Abstract]   [Full Text] [Related]  

  • 49. [The current situation of adolescents with cancer in pediatric hematology-oncology units in Spain. Results of a national survey].
    Lassaletta A; Andión M; Garrido-Colino C; Gutierrez-Carrasco I; Echebarria-Barona A; Almazán F; López-Ibor B; Ortega-Acosta MJ
    An Pediatr (Barc); 2013 Apr; 78(4):268.e1-7. PubMed ID: 23201346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: a position statement of SEOM, SEAP and SEFH.
    Garrido P; Aldaz A; Calleja MÁ; De Álava E; Lamas MJ; Martín M; Matías-Guiu X; Palacios J; Vera R
    Farm Hosp; 2017 Nov; 41(6):688-691. PubMed ID: 29112494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Barriers around access to abortion experienced by rural women in New South Wales, Australia.
    Doran FM; Hornibrook J
    Rural Remote Health; 2016; 16(1):3538. PubMed ID: 26987999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care.
    Liss DT; Baker DW
    Am J Prev Med; 2014 Mar; 46(3):228-36. PubMed ID: 24512861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Five years of EMA-approved systemic cancer therapies for solid tumours-a comparison of two thresholds for meaningful clinical benefit.
    Grössmann N; Del Paggio JC; Wolf S; Sullivan R; Booth CM; Rosian K; Emprechtinger R; Wild C
    Eur J Cancer; 2017 Sep; 82():66-71. PubMed ID: 28648700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SEOM guidelines 2013: a response to the needs of Spanish oncologists.
    Cruz-Hernández JJ; Rodríguez CA
    Clin Transl Oncol; 2013 Dec; 15(12):975-6. PubMed ID: 23925725
    [No Abstract]   [Full Text] [Related]  

  • 55. Access to essential medicines for children with cancer: a joint SIOP-CCI position statement.
    Denburg A; Arora B; Arora RS; Auste C; Bagai P; Barr R; Challinor J; Eden T; Grynzspancholc E; Hoffman R; Link M
    Lancet Oncol; 2017 Jan; 18(1):20-22. PubMed ID: 28049570
    [No Abstract]   [Full Text] [Related]  

  • 56. A "miracle" cancer drug in the era of social media: A survey of Brazilian oncologists' opinions and experience with phosphoethanolamine.
    Rêgo JF; Lopes G; Riechelmann RP; Sternberg C; Ferrari C; Fernandes G
    Rev Assoc Med Bras (1992); 2017 Jan; 63(1):70-77. PubMed ID: 28225882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.
    Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ
    J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increasing access to investigational drugs.
    Christian M
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):90-1. PubMed ID: 16163167
    [No Abstract]   [Full Text] [Related]  

  • 59. Cancer genomics: the challenge of drug accessibility.
    Lewin J; Siu LL
    Curr Opin Oncol; 2015 May; 27(3):250-7. PubMed ID: 25761223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Status of the medical oncology workforce. The American Society of Clinical Oncology.
    J Clin Oncol; 1996 Sep; 14(9):2612-21. PubMed ID: 8823341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.